by Elizabeth Fernandez, University of California, San Francisco Credit: Pixabay/CC0 Public Domain Clinicians rely daily on electrocardiograms (ECG) to detect common cardiovascular conditions, but accurate diagnoses require high levels of expertise. In a new study that reviewed nearly 1 million ECGs from 365,000 adults, an artificial intelligence algorithm exceeded the performance of a widely available commercial...
Category: <span>Anti-biotics</span>
Damage done by antibiotics could last for a year or maybe even be permanent
Everyone knows that antibiotics kill useful bacteria found in human gut. Some doctors prescribe probiotics to go with antibiotics to reduce potential adverse side effects. However, most people think that these negative effects are temporary. Now scientists from UCL found that the composition of oral and gut microbiomes is changed for at least a year...
New antibody for bowel disease
UConn molecular and cell biologist Michael Lynes and an international team of researchers have been awarded a patent for a novel antibody that could be proven safe than other drugs currently available. IBD and current treatments: More than 1.6 million Americans have IBD. Two of the most common forms of IBD are Crohn’s disease and...
Scientists develop new antibody for bowel disease
Sadikshya Bhandari, a Ph.D. student in molecular and cell biology, ‘passing cells,’ or feeding them, to keep them from overgrowing. UConn molecular and cell biologist Michael Lynes and an international team of researchers have been awarded a patent for a novel antibody therapeutic that may prove to be safer in the treatment of Inflammatory...
A new treatment for antibiotic resistant bacteria and infectious disease
A study, published in the American Journal of Respiratory and Critical Care Medicine, describes a new treatment pathway for antibiotic resistant bacteria and infectious diseases with benefits for patients and health care providers. Researchers from the University of Birmingham and Newcastle University found that the unusual approach of removing antibodies from the blood stream reduced the effects of...
Could maple syrup end superbugs? Extract boosts potency of antibiotics, study reveals
Maple syrup boosts the potency of antibiotics fighting deadly infections When strains were exposed to syrup mixed with the drug, results showed that 90 percent less antibiotic was needed The syrup’s antioxidants and anti-inflammatory properties are believed to help The overuse of antibiotics has given rise to drug-resistant superbugs, which are expected to kill more people...
One-two punch may floor worst infections
The figure shows an atomic force microscopy image of an E. coli bacterium treated with pentamidine. The magnifying glass highlights the high resolution topographical analysis and perturbations to the cell surface that are caused by pentamidine. McMaster University researchers have found a new way to treat the world’s worst infectious diseases, the superbugs that are...
New antiviral drug cuts cytomegalovirus infection, improves survival in patients undergoing donor stem cell transplant
In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital (BWH) has shown that a novel agent can protect against the most common viral infection that patients face after transplantation. The results represent a breakthrough in...
Unlocking the healing secrets of Komodo dragon blood
Not only is the Komodo dragon’s mouth full of razor-sharp teeth, but it contains bacteria that eventually poison any prey that gets away Downing a vial of Komodo dragon blood to fight a bacterial infection might sound like something prescribed by a meister on Game of Thrones, but new research shows that the substance might...
FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis
The U.S. Food and Drug Administration today cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia, and stopped in patients with sepsis. This is the first test to use...
- 1
- 2